Related Experiment Video
Updated: Sep 3, 2025

13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
17.6K
Integrated case-based clinical approach in understanding pathways, complexities, pitfalls and challenges in
Aashitha Dhavala1, Aditya Samitinjay2, Praveen Khairkar3
1Junior Resident in General Medicine, Kamineni Institute of Medical Sciences Narketpally, India.
American Journal of Neurodegenerative Disease
|July 25, 2022
Summary
Movement disorders and psychiatric symptoms frequently co-occur in neurodegenerative disorders. This association may indicate early organic psychopathology, even in limited case studies.
Area of Science:
- Neurology
- Psychiatry
- Clinical Medicine
Background:
- Presents a case series of 5 patients with neurodegenerative disorders from a tertiary care rural hospital in South India.
- Focuses on identifying common clinical themes among these patients.
Purpose of the Study:
- To identify an emerging common theme in patients with neurodegenerative disorders.
- To explore the relationship between movement disorders and psychiatric symptoms.
Main Methods:
- Thematic analysis of clinical data from a case series of 5 patients.
- Clinical analysis of patients attending Medicine or Psychiatry services.
Main Results:
- A common clinical theme emerged, linking movement disorders with psychiatric symptoms.
- Patients exhibited diverse illness trajectories despite the shared initial theme.
Conclusions:
- A consistent association between movement disorders and psychiatric symptoms was observed.
- Movement disorders may serve as early clinical markers for organic psychopathology.
- Acknowledges potential confounding factors like substance abuse and stress, which were considered.
Related Concept Videos
Alzheimer's Disease: Overview
663
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
663
Alzheimer's Disease: Treatment
258
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
258
Parkinson's Disease: Overview
690
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
690
Dementia
162
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
162
Methods of Documentation VI: Case Management Model
622
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
622
Disorders of the Nervous Tissue
1.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.5K

